Aaron Wealth Advisors LLC Buys 606 Shares of DocuSign, Inc. (NASDAQ:DOCU)

Aaron Wealth Advisors LLC boosted its position in DocuSign, Inc. (NASDAQ:DOCU) by 14.0% in the fourth quarter, HoldingsChannel.com reports. The firm owned 4,940 shares of the company’s stock after acquiring an additional 606 shares during the period. Aaron Wealth Advisors LLC’s holdings in DocuSign were worth $444,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the company. Itau Unibanco Holding S.A. purchased a new position in DocuSign in the third quarter worth $28,000. Brooklyn Investment Group purchased a new stake in shares of DocuSign during the third quarter worth about $33,000. Modus Advisors LLC acquired a new position in shares of DocuSign during the fourth quarter valued at about $36,000. Reston Wealth Management LLC purchased a new position in shares of DocuSign in the 3rd quarter valued at approximately $47,000. Finally, Wilmington Savings Fund Society FSB acquired a new stake in DocuSign in the 3rd quarter worth approximately $51,000. 77.64% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the stock. JMP Securities reiterated a “market outperform” rating and set a $124.00 price objective on shares of DocuSign in a research note on Tuesday, January 7th. Wells Fargo & Company increased their price objective on DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a report on Friday, December 6th. Citigroup lifted their target price on DocuSign from $87.00 to $113.00 and gave the stock a “buy” rating in a report on Friday, December 6th. Morgan Stanley increased their price target on shares of DocuSign from $62.00 to $97.00 and gave the stock an “equal weight” rating in a report on Friday, December 6th. Finally, Royal Bank of Canada restated a “sector perform” rating and set a $90.00 price objective (up from $57.00) on shares of DocuSign in a research note on Friday, December 6th. Three analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the stock. According to MarketBeat, DocuSign presently has an average rating of “Hold” and an average price target of $92.45.

Insider Activity

In other news, CFO Blake Jeffrey Grayson sold 8,000 shares of the stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $94.77, for a total value of $758,160.00. Following the completion of the sale, the chief financial officer now directly owns 101,439 shares in the company, valued at $9,613,374.03. This represents a 7.31 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Allan C. Thygesen sold 7,764 shares of the business’s stock in a transaction dated Friday, November 1st. The stock was sold at an average price of $69.95, for a total transaction of $543,091.80. Following the transaction, the chief executive officer now owns 107,825 shares in the company, valued at $7,542,358.75. The trade was a 6.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 693,537 shares of company stock worth $66,575,817 over the last 90 days. 1.66% of the stock is currently owned by company insiders.

DocuSign Stock Performance

DocuSign stock opened at $89.60 on Monday. The company’s fifty day moving average price is $88.76 and its 200 day moving average price is $70.38. The stock has a market capitalization of $18.10 billion, a P/E ratio of 18.47, a P/E/G ratio of 8.17 and a beta of 0.88. DocuSign, Inc. has a 1 year low of $48.70 and a 1 year high of $107.86.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.